Market revenue in 2023 | USD 1,159.9 million |
Market revenue in 2030 | USD 1,890.9 million |
Growth rate | 7.2% (CAGR from 2023 to 2030) |
Largest segment | Logistics & distribution |
Fastest growing segment | Logistics & distribution |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Logistics & distribution, Storage & retention, Packaging, labeling and blinding, Manufacturing, Comparator sourcing, Other services (solutions, ancillary supply) |
Key market players worldwide | Thermo Fisher Scientific Inc, Catalent Inc, PAREXEL, Almac Group, Piramal Pharma Solutions, DHL Group, FedEx Corp, UDG Healthcare, Marken, Walden Group, PCI Pharma Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial supply & logistics market will help companies and investors design strategic landscapes.
Logistics & distribution was the largest segment with a revenue share of 25.34% in 2023. Horizon Databook has segmented the Europe clinical trial supply & logistics market based on logistics & distribution, storage & retention, packaging, labeling and blinding, manufacturing, comparator sourcing, other services (solutions, ancillary supply) covering the revenue growth of each sub-segment from 2018 to 2030.
Europe has the most advanced technology and is the leading market for clinical trial supply and logistics market. Emerging regions in Europe, such as Eastern Europe, are still in development phase and can be considered favorable choices for clinical trials, as they are cost-effective and have a diverse patient pool.
A survey by Pharma IQ and Clinical Trial Supply Europe estimated that logistics and distribution are among the major outsourced functions in the market. Northwestern Europe is a developed center for clinical trials market.
Big firms are already established in this region, and it has advance regulatory bodies. For instance, in September 2020, UDG Healthcare received license approval for Medicinal Product (IMP) and Wholesale Distribution Authorisation (WDA) to support clinical activities from its facility in Heerenveen, Netherlands.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe clinical trial supply & logistics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe clinical trial supply & logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account